Search for: "SANDOZ, INC." Results 421 - 440 of 679
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Mar 2012, 8:24 pm by Patent Docs
Sandoz Inc. 1:12-cv-00248; filed February 29, 2012 in the District Court of Delaware The complaints in these cases are substantially identical. [read post]
12 Feb 2012, 8:34 pm by Patent Docs
Laboratories, Inc., Purdue Pharmaceuticals L.P., Rhodes Technologies, Board of Regents of the University of Texas Systems, Grunenthal GMBH • Defendant: Sandoz Inc. [read post]
7 Feb 2012, 2:25 pm by FDABlog HPM
District Court for the District of Columbia issued her decision in the long-running dispute concerning FDA’s July 23, 2010 approval of Sandoz Inc. [read post]
5 Feb 2012, 3:02 pm by Patent Docs
Sandoz Inc. 1:12-cv-00103; filed January 30, 2012 in the District Court of Delaware • Plaintiffs: Abbott Laboratories; Abbott Respiratory LLC • Defendant: Sandoz Inc. [read post]
31 Jan 2012, 6:13 am by Bexis
  Joe represents one of the successful moving defendants in the very recent decision that's described below.Take it away Joe:*****************On January 30, 2012, the United States District Court for the Eastern District of New York granted summary judgment in favor of Sandoz Inc., APP Pharmaceuticals, Inc., Ben Venue Laboratories, Inc., Teva Parenteral Medicines, Inc., and Hospira, Inc. with respect to all remaining plaintiffs in the… [read post]
29 Jan 2012, 8:59 pm by Patent Docs
Sandoz Inc. 1:12-cv-00074; filed January 24, 2012 in the District Court of Delaware The complaints in these cases are substantially identical. [read post]
15 Jan 2012, 8:27 pm by Patent Docs
Hunt • Defendant: Sandoz Inc. [read post]
10 Nov 2011, 12:50 pm by Bexis
Sandoz Pharmaceuticals Corp., 487 S.E.2d 70, 75 (Ga. [read post]
20 Oct 2011, 11:46 pm
On September 28, Bayer won a dismissal of U.S. antitrust claims that were made against it by Sandoz Inc. [read post]
27 Sep 2011, 4:02 pm by FDABlog HPM
District Court for the Eastern District of North Carolina in patent infringement litigation concerning Sandoz, Inc. [read post]
19 Sep 2011, 9:36 am by Schachtman
With the exception of a few evidence scholars, Federal Rule of Evidence 703 is ignored or misunderstood in practice. [read post]
16 Sep 2011, 11:03 am by eithurburn@getnicklaw.com
Sandoz, Inc. is the latest company to fall in an ongoing series of litigation surrounding fraudulent manipulation of Medicaid’s Average Wholesale Price by pharmaceutical companies. [read post]
15 Sep 2011, 5:00 am by Bexis
Dorsey Laboratories, Division of Sandoz, Inc., 845 F.2d 364, 368 (1st Cir. 1988) (applying Puerto Rico law). [read post]
9 Sep 2011, 8:30 am by Phil
Barr Laboratories Inc, a unit of Teva, and Novartis (NOVN.VX) (NVS.N) unit Sandoz filed abbreviated new drug applications (ANDA) in 2009 to make a generic version of the drug. [read post]
8 Sep 2011, 4:00 am by Philip Thomas
Mississippi Recovers $38 Million in Drug Litigation Wednesday's Clarion-Ledger reports that the State is recovering $38 million from Sandoz, Inc. for inflating wholesale prices of prescription drugs: Judge Thomas Zebert awarded Mississippi $23,661,618 in compensatory damages, $11,830,809 in punitive damages and $2,699,000 in penalties, for a total of $38,191,427. [read post]
7 Sep 2011, 4:22 am by Marie Louise
  Highlights this week included: US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al (Inventive Step) (Orange Book Blog) (Patently-O) (Patent Docs) (Patent Docs) (IPBiz) (Patent Law Practice Center) (Patent Baristas) US: FTC issues long-awaited final report on authorized generics; report examines both the short-term effects and long-term impact on competition and drug prices (FDA Law Blog) (Orange Book Blog)   Please join the… [read post]